Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Semerád, Lukáš
18  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

P669: ANALYSIS OF FACTORS INFLUENCING THE DECISION TO STOP ..:

Semerad, Lukas ; Žáčková, Daniela ; Belohlavkova, Petra...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429555/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
2

Gemtuzumab ozogamicin plus midostaurin in conjunction with ..:

Weinbergerová, Barbora ; Čerňan, Martin ; Kabut, Tomáš...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542832/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
3

Gemtuzumab ozogamicin plus midostaurin in conjunction with ..:

Weinbergerová Barbora ; Čerňan Martin ; Kabut Tomáš...
https://is.muni.cz/publication/2300078.  , 2023
Link: https://is.muni.cz/publi..
 
?
4

Cévní nežádoucí účinky u pacientů s chronickou myeloidní le..:

Čičátková Petra ; Žáčková Daniela ; Horňák Tomáš...
https://is.muni.cz/publication/2366522.  , 2023
Link: https://is.muni.cz/publi..
 
?
5

Retina Recognition Using Crossings and Bifurcations:

Semerád, Lukáš ; Drahanský, Martin
ISBN:978-1-78985-332-2.  , 2021
Link: https://mts.intechopen.c..
 
?
6

Chromothripsis in acute myeloid leukemia: Biological featur..:

Fontana, Maria Chiara ; Marconi, Giovanni ; Feenstra, Jelena D. Milosevic...
info:eu-repo/semantics/altIdentifier/pmid/29472722.  , 2018
Link: http://hdl.handle.net/11..
 
?
7

Chromothripsis in acute myeloid leukemia: biological featur..:

Fontana, Maria Chiara ; Marconi, Giovanni ; Feenstra, Jelena D. Milosevic...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6035145/.  , 2018
Link: http://www.ncbi.nlm.nih...
 
?
8

Chromothripsis in Acute Myeloid Leukemia: biological featur..:

Fontana, Maria Chiara ; Marconi, Giovanni ; Milosevic Feenstra, Jelena D...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892717/.  , 2017
Link: http://www.ncbi.nlm.nih...
 
?
9

Mechanism of impaired glucose metabolism during nilotinib t..:

Racil, Zdenek ; Razga, Filip ; Drapalova, Jana...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789473.  , 2013
Link: http://www.ncbi.nlm.nih...
 
?
10

P669: ANALYSIS OF FACTORS INFLUENCING THE DECISION TO STOP ..:

Lukas Semerad ; Daniela Žáčková ; Petra Belohlavkova...
http://journals.lww.com/10.1097/01.HS9.0000969580.70530.bf.  , 2023
Link: https://doi.org/10.1097/..
 
?
11

Image_3_Dendritic Cell-Based Immunotherapy in Advanced Sarc..:

Eva Hlavackova ; Katerina Pilatova ; Dasa Cerna...
doi:10.3389/fonc.2019.01034.s004.  , 2019
Link: https://doi.org/10.3389/..
 
?
12

Data_Sheet_1_Dendritic Cell-Based Immunotherapy in Advanced..:

Eva Hlavackova ; Katerina Pilatova ; Dasa Cerna...
doi:10.3389/fonc.2019.01034.s001.  , 2019
Link: https://doi.org/10.3389/..
 
?
13

Table_3_Dendritic Cell-Based Immunotherapy in Advanced Sarc..:

Eva Hlavackova ; Katerina Pilatova ; Dasa Cerna...
doi:10.3389/fonc.2019.01034.s007.  , 2019
Link: https://doi.org/10.3389/..
 
?
14

Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and ..:

Eva Hlavackova ; Katerina Pilatova ; Dasa Cerna...
https://www.frontiersin.org/article/10.3389/fonc.2019.01034/full.  , 2019
Link: https://doi.org/10.3389/..
 
?
15

Image_1_Dendritic Cell-Based Immunotherapy in Advanced Sarc..:

Eva Hlavackova ; Katerina Pilatova ; Dasa Cerna...
doi:10.3389/fonc.2019.01034.s002.  , 2019
Link: https://doi.org/10.3389/..
 
1-15